World Journal of Neuroscience
Vol.2 No.1(2012), Paper ID 17722, 8
pages
DOI:10.4236/wjns.2012.21002
Clinical and pharmacological properties of new oral anticoagulants for the prevention of cerebral thromboembolism: Factor Xa and thrombin inhibitors
Yaroslav Winter, Richard Dodel, Alexei Korchounov, Martin Grond, Wolfgang H. Oertel, Tobias Back
Department of Neurology, Philipps-University Marburg, Marburg, Germany
Department of Neurology, Philipps-University Marburg, Marburg, Germany
Clinic of Neurology, Marienhospital Kevelaer, Kevelaer, Germany
Department of Neurology, Kreisklinikum Siegen, Siegen, Germany
Department of Neurology, Philipps-University Marburg, Marburg, Germany
Department of Neurology, Saxon Hospital Arnsdorf, Arnsdorf/Dresden, Germany
Copyright © 2012 Yaroslav Winter, Richard Dodel, Alexei Korchounov, Martin Grond, Wolfgang H. Oertel, Tobias Back et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Winter, Y. , Dodel, R. , Korchounov, A. , Grond, M. , Oertel, W. and Back, T. (2012) Clinical and pharmacological properties of new oral anticoagulants for the prevention of cerebral thromboembolism: Factor Xa and thrombin inhibitors.
World Journal of Neuroscience,
2, 7-14. doi:
10.4236/wjns.2012.21002.